Glaucoma Treatment Market By Disease Type (Open Angle Glaucoma, Angle Closure Glaucoma, Congenital Glaucoma, and Others), By Treatment (Drugs {Prostaglandins Analogues, Beta-blockers, Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Others}, Surgery {Trabeculectomy, Glaucoma Drainage Devices, Minimally Invasive Glaucoma Surgery}, Laser Therapy {Laser Trabeculoplasty, Laser Peripheral Iridotomy, Cyclophotocoagulation}), By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers (ASCs), Others ), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Sep 2024 | Report ID: MI1061 | 215 Pages
Report Coverage:
By Disease Type
- Open Angle Glaucoma
- Angle Closure Glaucoma
- Congenital Glaucoma
- Others
By Treatment
- Drugs
- Prostaglandins Analogues
- Beta-blockers
- Adrenergic Agonists
- Carbonic Anhydrase Inhibitors
- Others
- Surgery
- Trabeculectomy:
- Glaucoma Drainage Devices
- Minimally Invasive Glaucoma Surgery
- Laser Therapy
- Laser Trabeculoplasty
- Laser Peripheral Iridotomy
- Cyclophotocoagulation
By End User
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgical Centers (ASCs)
- Others
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Aerie Pharmaceuticals
- Glaukos Corporation
- Ocular Therapeutix
- Eyevance Pharmaceuticals
- Horizon Therapeutics
- Santen Pharmaceutical
- Inotek Pharmaceuticals
- Xoma Corporation
- Kala Pharmaceuticals
- LumiThera
- Corneal Therapeutics
- Bausch + Lomb
- Allergan (now part of AbbVie)
- Alcon (part of Novartis)
- Regeneron Pharmaceuticals
- DePuy Synthes
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.